U.S. Markets closed

Solazyme shares should be bought on weakness, says Pacific Crest

Pacific Crest believes that disagreements over timing likely caused the dissolution of the algae food product joint venture of Solazyme and Roquette. The firm lowered its 2014 estimates for Solazyme, as it notes that the company has lost a funding source. However, the firm continues to be upbeat on the company's 2014 and 2015 outlook ,and it keeps an Outperform rating on the shares.